The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

U.S. Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...

US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...

Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy ...

U.S. Food and Drug Administration commissioner Marty Makary has appointed former biotech executive George Tidmarsh as the ...